Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 1 4Phase 2 3Phase 1/2 2Phase 3 1

Status

Terminated 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 60Gastrointestinal 39Genitourinary 24Head & Neck 22Thoracic 21Gynecologic 19Tumor-Agnostic 18Other hematologic neoplasm 9Lymphoid 9Sarcoma 8CNS 7Dermatologic 6Plasma cell 4Other neoplasm 3Other 3Other solid neoplasm 2NET 1Endocrine 1

Conditions

Multiple Myeloma 4Neoplasms, Plasma Cell 1Lymphoma 1Lung Neoplasms 1Gastrointestinal Neoplasms 1Breast Neoplasms 1Anosmia 1

Interventions

Cyclophosphamide 20fludarabine phosphate 14Peripheral Blood Stem Cell Transplantation 13Dexamethasone 13Cyclosporine 12Whole-Body Irradiation 11fludarabine 10Exercise 10Antilymphocyte Serum 10Melphalan 9Busulfan 9Blood Specimen Collection 9Mycophenolic Acid 8Therapeutics 7Filgrastim 7Bortezomib 7Standard of Care 6Radiotherapy 6Behavior Therapy 6Acupuncture Therapy 6pomalidomide 5Specimen Handling 5Palliative Care 5Methotrexate 5Granulocyte Colony-Stimulating Factor 5Etoposide 5Educational Status 5daratumumab 4Surveys and Questionnaires 4Stem Cell Transplantation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Surveys and Questionnaires × Plasma cell × Clear all
NCT07226609 2026-05-05

A Dietary Study for People With Multiple Myeloma

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
220 enrolled
Plasma cell

Multiple Myeloma

NCT05587972 2026-02-23

Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring

Carevive Systems, Inc.

Phase NA Active not recruiting
100 enrolled
BreastGastrointestinalPlasma cellThoracic

Breast Neoplasms, Gastrointestinal Neoplasms, Lung Neoplasms, Multiple Myeloma

NCT04716153 2026-01-20

RE-NEZ-SENS

University Hospital, Montpellier

Phase NA Terminated
5 enrolled
LymphoidPlasma cell

Anosmia, Lymphoma, Multiple Myeloma

NCT01927718 2019-04-29

Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT)

M.D. Anderson Cancer Center

Phase NA Terminated
10 enrolled 5 charts
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡